FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileProteomics International Laboratories Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PIQ.AX
Proteomics International Laboratories Ltd. Stock AnalysisComprehensive stock analysis for Proteomics International Laboratories Ltd. (PIQ.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPIQ.AX
PIQ.AX
Proteomics International Laboratories Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PIQ.AX
  1. Home
  2. Stocks
  3. Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.

🇦🇺PIQ.AX•ASX

Proteomics International Laboratories Ltd.

🇦🇺PIQ.AX•ASX

Your view on PIQ.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Proteomics International Laboratories Ltd.

Industry
Medical - Care Facilities
Sector
Healthcare
CEO
David N. Morris
Headquarters
Harry Perkins Institute of Medical Research, Nedlands, WA, AU
Industry
Medical - Care Facilities
Sector
Healthcare
CEO
David N. Morris
Headquarters
Harry Perkins Institute of Medical Research, Nedlands, WA, AU
Description

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD).

The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment.

It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for type 1 diabetes, diabetic retinopathy, and diabetic neuropathy; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; and Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy.

The company also offers analytical services, such as specialist contract research focusing on biomarker discovery, biosimilars quality control, and pharmacokinetic testing for clinical trials.

It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Perth, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Proteomics International Laboratories Ltd.. Starting points for Proteomics International Laboratories Ltd.: EPS -AUD 0.07, beta -0.38 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Proteomics International Laboratories Ltd.. Proteomics International Laboratories Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Proteomics International Laboratories Ltd.. Trailing twelve-month EPS for Proteomics International Laboratories Ltd. stands at -AUD 0.07. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00AUD 0.00−AUD 0.04AUD 0.00
Lowest estimateAUD 0.00AUD 0.00−AUD 0.04AUD 0.00
Highest estimateAUD 0.00AUD 0.00−AUD 0.04AUD 0.00
Number of analysts0010
A year ago——−AUD 0.05—
Growth vs a year ago——+25.1%—

Revenue estimates

TotalThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 122430.00AUD 357440.00AUD 5.90MAUD 113.30M
Lowest estimateAUD 122430.00AUD 357440.00AUD 5.90MAUD 113.30M
Highest estimateAUD 122430.00AUD 357440.00AUD 5.90MAUD 113.30M
Number of analysts1111
A year ago——AUD 278015.00—
Growth vs a year ago——+2022.2%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Proteomics International Laboratories Ltd.. Proteomics International Laboratories Ltd. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold PIQ.AX20 companies
Compare PIQ.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ADO.AXAnteoTech LimitedBasic MaterialsChemicals - Specialty—
AGN.AXArgenica Therapeutics LtdHealthcareBiotechnology—
ATX.AXAmplia Therapeutics LimitedHealthcareBiotechnology—
CSX.AXCleanSpace Holdings LimitedHealthcareMedical - Devices—
CYP.AXCynata Therapeutics LimitedHealthcareBiotechnology—
DOC.AXDoctor Care Anywhere Group PLCHealthcareMedical - Healthcare Information Services—
NOX.AXNoxopharm LimitedHealthcareBiotechnology—
NSB.AXNeuroScientific Biopharmaceuticals LimitedHealthcareBiotechnology—
More Medical - Care Facilities companies
TickerTypeCompanySectorExchangeMkt cap
ETAOFETAO International Co., Ltd.HealthcareOTC$2,049
EUDAEUDA Health Holdings LimitedHealthcareNASDAQ$45.0M
EUDAWEUDA Health Holdings LimitedHealthcareNASDAQ$635,166
EVGRFChina Evergrande New Energy Vehicle Group LimitedHealthcareOTC$11.9M
EXE.TOExtendicare Inc.HealthcareTSX$2.7B
EXETFExtendicare Inc.HealthcareOTC$1.7B
FCGDFirst Colombia Gold Corp.HealthcareOTC$483,789
FCHSFirst Choice Healthcare Solutions, Inc.HealthcareOTC$131,833
FMCQFFresenius Medical Care AG & Co. KGaAHealthcareOTC$14.3B
FMSFresenius Medical Care AG & Co. KGaAHealthcareNYSE$11.3B
FOXOFOXO Technologies Inc.HealthcareOTC$8,997
FPCGFirst Physicians Capital Group, Inc.HealthcareOTC$10.1M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Proteomics International Laboratories Ltd.. Coverage tracks Proteomics International Laboratories Ltd. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Proteomics International Laboratories Ltd.

PIQ.AX AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1